ABT-263 sensitizes TRAIL-resistant hepatocarcinoma cells by downregulating the Bcl-2 family of anti-apoptotic protein | |
Wang, Guan; Zhan, Yao; Wang, Haiqing; Li, Wenhua | |
刊名 | CANCER CHEMOTHERAPY AND PHARMACOLOGY
![]() |
2012 | |
卷号 | 69期号:3 |
关键词 | TRAIL ABT-263 Hepatocarcinoma cells Apoptosis |
ISSN号 | 0344-5704 |
DOI | 10.1007/s00280-011-1763-0 |
URL标识 | 查看原文 |
收录类别 | SCIE |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4087604 |
专题 | 武汉大学 |
推荐引用方式 GB/T 7714 | Wang, Guan,Zhan, Yao,Wang, Haiqing,et al. ABT-263 sensitizes TRAIL-resistant hepatocarcinoma cells by downregulating the Bcl-2 family of anti-apoptotic protein[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY,2012,69(3). |
APA | Wang, Guan,Zhan, Yao,Wang, Haiqing,&Li, Wenhua.(2012).ABT-263 sensitizes TRAIL-resistant hepatocarcinoma cells by downregulating the Bcl-2 family of anti-apoptotic protein.CANCER CHEMOTHERAPY AND PHARMACOLOGY,69(3). |
MLA | Wang, Guan,et al."ABT-263 sensitizes TRAIL-resistant hepatocarcinoma cells by downregulating the Bcl-2 family of anti-apoptotic protein".CANCER CHEMOTHERAPY AND PHARMACOLOGY 69.3(2012). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论